Globus Medical (GMED) Tops Q2 EPS by 12c
Get Alerts GMED Hot Sheet
Join SI Premium – FREE
Globus Medical (NYSE: GMED) reported Q2 EPS of $0.56, $0.12 better than the analyst estimate of $0.44. Revenue for the quarter came in at $251 million versus the consensus estimate of $224.64 million.
GUIDANCE:
Globus Medical sees FY2021 EPS of $1.89-$2.00, versus the consensus of $1.89. Globus Medical sees FY2021 revenue of $925-950 million, versus the consensus of $926 million.
For earnings history and earnings-related data on Globus Medical (GMED) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BayCom Corp (BCML) Misses Q1 EPS by 4c
- United Bancshares, Inc. (UBOH) Reports Q1 EPS of $0.61
- United Security Bancshares (UBFO) Reports Q1 EPS of $0.24
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!